Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
Summary
The goal of the Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS) is to define the immune responses that can either protect or harm during infection. The JH-EPICS team will evaluate the immune responses required to detect the presence of SARS-CoV-2, initiate inflammatory responses, eliminate infected cells, and engage the antibody responses against the virus in COVID-19 patients. Using statistical analyses and modeling, JH-EPICS will identify the variables, such as demographic (e.g., age, sex, gender, race, and ethnicity) and clinical (e.g., severity of COVID-19 and comorbidities) factors, that predict COVID-19 immune responses and outcomes.